My prescription
Edit
250MCG, Roflumilast (30 Tablets)
Select pharmacy
CVS
$52.83
COUPON PRICE
Rite Aid
$71.64
COUPON PRICE
Walgreens
$90.30
COUPON PRICE
Walmart
$98.82
COUPON PRICERoflumilast savings card
Show this card to your pharmacistCVS
$52.83
BIN
ID
PCN
GRP
019876
LH20D09672
CHIPPO
LHX
Powered by
More prescriptions for seborrheic dermatitis
More prescriptions for seborrheic dermatitis
Roflumilast dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 250MCG | 30 Tablets | $52.83 | $1.76 |
| 500MCG | 30 Tablets | $14.42 | $0.48 |
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
Roflumilast Warnings
The safety and warning information provided here is crucial for understanding the potential risks associated with the use of this medication. Please review these details carefully and discuss any concerns with your healthcare provider.
Not for Acute COPD Symptoms: Roflumilast (Daliresp) should not be used for the immediate relief of sudden COPD symptom exacerbations. It is not a rescue medication. In cases of a COPD flare-up, use your prescribed rescue inhaler for rapid relief.
Mood and Behavior Changes: This medication may increase the risk of mood alterations, including insomnia, anxiety, and depression. Although infrequent, some individuals have experienced suicidal thoughts or behaviors. This risk is heightened in those with a history of mental health issues.
Weight Loss: A common side effect of roflumilast (Daliresp) is weight loss. Clinical studies have shown that some individuals lost between 5% to 10% or more of their body weight after a year of usage. Most regained the weight after discontinuing the medication.
Drug Interactions: Roflumilast (Daliresp) may interact with various medications, potentially reducing its effectiveness in managing COPD. Medications such as rifampin, carbamazepine (Tegretol), and phenytoin (Dilantin) can decrease the levels of roflumilast in the body.
Contraindications: The use of this medication is not advised for individuals with moderate or severe liver problems due to potential serious health risks. Consult your healthcare provider if this applies to you.
In case of an overdose, seek emergency medical attention immediately.
Roflumilast Side Effects
Common side effects:
- Diarrhea
- Weight loss
- Nausea
- Headache
- Dizziness
- Loss of appetite
- Upset stomach
- Difficulty sleeping
- Back pain
- Runny nose
- Sinus inflammation
- Flu-like symptoms
Muscle spasms
Less common but important to monitor:
- Fast or irregular heartbeat
Trouble sleeping
Serious side effects:
- Anxiety
- Depression
- Suicidal thoughts or behavior
- Tremors
- Allergic reaction (rash, itching, swelling, severe dizziness, difficulty breathing)
Roflumilast Interactions
Interactions with high risk of serious adverse effects and should be avoided:
- Ceritinib
- Clarithromycin
- Fosphenytoin
- Phenytoin
- Rifampin
Interactions with moderate risk that may require dose adjustment, closer monitoring, or timing changes:
- Cimetidine
- Enoxacin
- Erythromycin
- Ethinyl Estradiol
- Fluvoxamine
- Gestodene
- Ketoconazole
What type of medication is roflumilast?
Roflumilast is a phosphodiesterase-4 (PDE4) inhibitor. It is used to reduce the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations.
What are the side effects of roflumilast?
Roflumilast may cause several side effects. Common side effects include diarrhea, weight loss, nausea, headache, and back pain. Some individuals may also experience insomnia, dizziness, or decreased appetite. It is important to monitor for any severe reactions such as mood changes, depression, or suicidal thoughts, and report these to a healthcare provider immediately. As with any medication, if any unusual or severe side effects occur, it is advisable to seek medical attention.
How does roflumilast improve breathing?
Roflumilast improves breathing by reducing inflammation in the airways. It is a phosphodiesterase-4 (PDE4) inhibitor, which helps decrease the frequency of flare-ups or worsening of symptoms in individuals with severe chronic obstructive pulmonary disease (COPD). By targeting the inflammatory process, it helps to relax the airways and improve airflow, making it easier to breathe.
Are DALIRESP and roflumilast the same thing?
Yes, DALIRESP is the brand name for the medication roflumilast. They are the same medication.
What is the generic version of DALIRESP?
The generic version of DALIRESP is roflumilast.